glp 1 drugs blindness There’s been a lot of talk lately about GLP-1 medications like Ozempic and semaglutide and their potential connection to eye issues. 👀, But what’s actually being reported… and what does it mean for Popular weight loss and diabetes
Description
Obesity is not only a major risk factor for the development of T2D but also a risk factor for developing cardiovascular disease, sleep apnea and chronic pulmonary disease, various cancer manifestations, osteoarthritis, reflux disease, gallstones, nonalcoholic steatohepatitis (NASH), and depression (1822)
26,111 Additionally, DPP4 inhibitors have been shown to possess anti-inflammatory properties
doi: 10.1016/j.ajpath.2016.11.009
Studies show a dramatic initial weight loss that slows after 60 weeks as the appetite-suppressive effects appear to diminish
